CBIO CRESCENT BIOPHARMA, INC.

$17.65 -2.41%

Healthcare · Pharmaceutical Preparations

CRESCENT BIOPHARMA, INC. (CBIO) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $487 million. Shares last traded at $17.65, 35.6% below their 52-week high. Over the past year the stock is up 35.7%. CBIO trades at a price-to-earnings ratio of 3161.22, above the Pharmaceutical Preparations median of 16.82. Net profit margin is 1.4%, above the peer median of -0.1%.

Market Cap

$487M

Shares Out

27.6M

EPS (TTM)

$-1.28

P/E Ratio

3161.22

P/S Ratio

44.88

P/B Ratio

2.65

Dividend / Share

—

Dividend Yield

—

52-Week High

$27.41

52-Week Low

$8.80

Volume

5,637

Avg Vol (3m)

16,120.778

Performance

-3.55%

-4.54%

+65.88%

+37.25%

YTD

+59.30%

+35.66%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

44.36

SMA (50)

$19.80

SMA (200)

$14.29

Price vs SMA50

-10.87%

Price vs SMA200

+23.50%

ATR (14)

$1.43

Financials

Revenue

$11M

Net Income

$0M

Gross Margin

—

Operating Margin

-1407.5%

Net Margin

1.4%

Return on Equity

0.1%

Return on Assets

0.1%

Current Ratio

13.78

Debt / Equity

0.08

Revenue Growth (YoY)

—

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
FY 2024	$-0.59	2025-02-13
Q3 2024	$-0.48	2024-11-13
Q2 2024	$-0.32	2024-08-08
Q1 2025	$-0.04	2025-05-14
FY 2024	$-0.58	2025-02-13
Q3 2024	$-0.44	2024-11-13

Full earnings history →

Pharmaceutical Preparations peers

CBIO vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

3161.22 / 16.82 med

+18700% premium

P/S vs peers

44.88 / 3.54 med

+1169% premium

Net margin vs peers

1.4% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.